MedPacto
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
92 Myeongdal-ro, Seocho-gu, Seoul, 06668...Phone Number
+82 269380200Website
www.medpacto.comRevenue
$6.4 MillionIndustry
About MedPacto
MedPacto is a genome-based drug discovery and clinical-stage biotechnology company dedicated to developing innovative therapeutics targeting cancer and autoimmune diseases. MedPacto's expertise lies in utilizing genome-based methods to identify novel targets and to develop first-in-class and best-in-class drugs. MedPacto is based in Suwon, South Korea and is a subsidiary of TheragenEtex, a KOSDAQ-listed Korean company that is a leading player in the genomics industry.Explore more
SIC Code 87,873NAICS Code 54,541Show moreMedPacto Org Chart
Show More
MedPacto Tech Stack
A closer look at the technologies used by MedPacto
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MedPacto
Sign Up For FreeTo access detailed company insights
MedPacto is a genome-based drug discovery and clinical-stage biotechnology company dedicated to developing innovative therapeutics targeting cancer and autoimmune diseases. MedPacto's expertise lies in utilizing genome-based methods to identify novel targets and to develop first-in-class and best-in-class drugs. MedPacto is based in Suwon, South Ko... Read More